Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Etoposide, sold under the brand name Vepesid among others, is a chemotherapy medication used for the treatments of a number of types of cancer including testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer. It is also used for hemophagocytic lymphohistiocytosis. It is used by mouth or injection into a vein.
History & Applications
Explore the main themes, entities and connections around Etoposide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cancer used dna blood drug effects administration cell topoisomerase side podophyllotoxin pressure low leukemia medical iv name mouth form given
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Etoposide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Etoposide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Etoposide | ATC code | L01CB01 (WHO) | 1.00 | infobox |
| Etoposide | Bioavailability | Highly variable, 25 to 75% | 1.00 | infobox |
| Etoposide | CAS Number | 33419-42-0 Y | 1.00 | infobox |
| Etoposide | ChEBI | CHEBI:4911 Y | 1.00 | infobox |
| Etoposide | ChEMBL | ChEMBL44657 Y | 1.00 | infobox |
| Etoposide | ChemSpider | 33510 Y | 1.00 | infobox |
| Etoposide | CompTox Dashboard (EPA) | DTXSID5023035 | 1.00 | infobox |
| Etoposide | DrugBank | DB00773 Y | 1.00 | infobox |
| Etoposide | ECHA InfoCard | 100.046.812 | 1.00 | infobox |
| Etoposide | Elimination half-life | Oral: 6 h., IV: 6-12 h., IV in children: 3 h. | 1.00 | infobox |
| Etoposide | Excretion | Kidney and fecal | 1.00 | infobox |
| Etoposide | Formula | C29H32O13 | 1.00 | infobox |
| Etoposide | IUPHAR/BPS | 6815 | 1.00 | infobox |
| Etoposide | KEGG | D00125 Y | 1.00 | infobox |
| Etoposide | KEGG | as salt: D04107 Y | 1.00 | infobox |
| Etoposide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Etoposide | Legal status | US: ℞-only | 1.00 | infobox |
| Etoposide | MedlinePlus | a684055 | 1.00 | infobox |
| Etoposide | Melting point | 243.5 °C (470.3 °F) | 1.00 | infobox |
| Etoposide | Metabolism | Liver (CYP3A4 involved) | 1.00 | infobox |
| Etoposide | Molar mass | 588.562 g·mol−1 | 1.00 | infobox |
| Etoposide | Other names | VP-16; VP-16-213 | 1.00 | infobox |
| Etoposide | Pregnancy category | AU: D | 1.00 | infobox |
| Etoposide | Pronunciation | /ˌɛtoʊˈpoʊsaɪd/ | 1.00 | infobox |
| Etoposide | Protein binding | 97% | 1.00 | infobox |
| Etoposide | PubChem CID | 36462 | 1.00 | infobox |
| Etoposide | Routes of administration | By mouth, intravenous | 1.00 | infobox |
| Etoposide | Trade names | Etopophos, Toposar, Vepesid, others | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.